๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Venous thromboembolism in malignant glioma patients treated by chemoradiotherapy

โœ Scribed by A. Silvani; A. Salmaggi; M. Eoli; E. Lamperti; A. Boiardi

Book ID
106267748
Publisher
Springer Milan
Year
2003
Tongue
English
Weight
23 KB
Volume
24
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Venous thromboembolism in malignant glio
Venous thromboembolism in malignant gliomas
โœ E. O. JENKINS; D. SCHIFF; N. MACKMAN; N. S. KEY ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 205 KB
ABO blood group is a potent risk factor
ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas
โœ Michael B. Streiff; Jodi Segal; Stuart A. Grossman; Thomas S. Kickler; Edward G. ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 201 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND Venous thromboembolism (VTE) is a common cause of morbidity and mortality among patients with malignant gliomas. To investigate the pathogenesis of VTE and facilitate targeted prophylaxis strategies, the authors aimed to characterize VTE risk factors in these patients. #